1 medication hotmail.com yahoo.com news 2019

It seems like you're looking for information on medications and news from 2019. Here's a summary of some notable medication-related news from 2019:

New Medications Approved in 2019:

1. Brexafemme (ibrexafungerp): An oral medication for the treatment of vulvovaginal yeast infections caused by Candida.
2. Zepzelca (lurbinectedin): An injectable medication for the treatment of small cell lung cancer.
3. Orilissa (elagolix): An oral medication for the treatment of moderate to severe endometriosis pain.
4. Kymriah (tisagenlecleucel): A CAR-T cell therapy for the treatment of certain types of blood cancers, including acute lymphoblastic leukemia and diffuse large B-cell lymphoma.
5. Breyanzi (lisocabtagene vicleucel): A CAR-T cell therapy for the treatment of certain types of blood cancers, including large B-cell lymphoma.

Notable Medication Recalls in 2019:

1. Valsartan: Several manufacturers recalled certain lots of valsartan, a blood pressure medication, due to contamination with a potential carcinogen.
2. Metformin: Some manufacturers recalled certain lots of metformin, a diabetes medication, due to contamination with a potential carcinogen.
3. Zantac (ranitidine): The FDA recalled certain lots of ranitidine, a heartburn medication, due to contamination with a potential carcinogen.

Other Medication-Related News in 2019:

1. Opioid Crisis: The FDA took steps to address the opioid crisis, including approving new medications to treat opioid addiction and increasing oversight of opioid manufacturers.
2. Gene Therapy: The FDA approved several gene therapies in 2019, including Luxturna for treating inherited vision loss and Zolgensma for treating spinal muscular atrophy.
3. Personalized Medicine: The FDA approved several personalized medications in 2019, including Kymriah and Breyanzi, which are tailored to individual patients' genetic profiles.

I hope this summary is helpful!